Abiopharma

Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule

Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference

Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation

enGene Achieves Target Enrollment Milestone for LEGEND Trial Pivotal Cohort

Vivos Inc Files Critical Patent For Hydrogel Electron Beam Sterilization

DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market

Lexicon Pharmaceuticals Announces Presentation of Diabetic Peripheral Neuropathic Pain Patient Insights at PAINWeek 2025

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

New Form 6-K - Valneva SE Filed: 2025-09-03 AccNo: 0001836564-25-000014 Size: 46 KB

Silo Pharma Notification (SILO)

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

New Form 144 - NewAmsterdam Pharma Co N.V. Filed: 2025-09-03 AccNo: 0002004379-25-000005 Size: 4 KB

New Form 8-K - STRATA Skin Sciences, Inc. Filed: 2025-09-03 AccNo: 0001213900-25-083709 Size: 582 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Biomerica, Inc. - United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use